MARKET

ALVO

ALVO

Alvotech
NASDAQ
5.14
+0.02
+0.39%
After Hours: 5.12 -0.02 -0.39% 19:25 02/09 EST
OPEN
5.16
PREV CLOSE
5.12
HIGH
5.27
LOW
5.00
VOLUME
396.85K
TURNOVER
--
52 WEEK HIGH
13.08
52 WEEK LOW
4.320
MARKET CAP
1.60B
P/E (TTM)
24.57
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ALVO last week (0202-0206)?
Weekly Report · 16h ago
Alvotech higher on positive data backing biosimilar to Takeda’s Entyvio
Seeking Alpha · 4d ago
Alvotech Hits Pivotal Milestone With Positive PK Data for Entyvio Biosimilar AVT80
TipRanks · 4d ago
Alvotech's AVT80 Biosimilar To Entyvio Passes Key Pharmacokinetic Study, Showing Safety And Immunogenicity Profiles In Healthy Participant
Benzinga · 4d ago
Alvotech meldet erfolgreiche Ergebnisse einer PK-Studie für Biosimilar zu Entyvio
Reuters · 4d ago
Alvotech Reports Positive Results for Biosimilar Entyvio in Pivotal Study
Reuters · 4d ago
ALVOTECH ANNOUNCES POSITIVE TOP-LINE RESULTS FROM PIVOTAL PHARMACOKINETIC STUDY FOR PROPOSED BIOSIMILAR TO ENTYVIO®
Reuters · 4d ago
ALVOTECH SA - STUDY MET ALL PRIMARY ENDPOINTS FOR AVT80
Reuters · 4d ago
More
About ALVO
Alvotech SA is a biotechnology company. The Company is focused on the development and manufacture of biosimilar medicines for patients globally. It is engaged in developing a pipeline of monoclonal antibodies that target a variety of therapeutic areas including inflammatory diseases, oncology, and ophthalmology. The Company’s pipeline contains eight biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, respiratory disease, and cancer. Its products pipeline includes AVT02, AVT04, AVT23, AVT03, AVT05, AVT06, AVT16, and AVT33. Its AVT02 is a monoclonal antibody and a biosimilar to Humira (adalimumab). AVT04 is a monoclonal antibody and a biosimilar candidate to Stelara (ustekinumab). It has formed a network of strategic commercial partnerships to provide global reach and leverage expertise in markets that include the United States (U.S.), Europe, Japan, China, and other Asian countries and large parts of South America, Africa, and the Middle East.

Webull offers Alvotech SA stock information, including NASDAQ: ALVO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ALVO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ALVO stock methods without spending real money on the virtual paper trading platform.